Pharmacological, therapeutic and toxicological properties of furazolidone: Some recent research

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Some of the recent publications on the pharmacological, therapeutic and toxicological properties of the antimicrobial agent furazolidone (FZ) are briefly reviewed. In animals, most of the recently published papers focus on (1) the methodology of measuring the residues of the drug and its metabolites in edible tissues: (2) the carcinogenicity and genotoxicity of FZ; (3) the cellular and molecular basis of FZ-induced cardiomyopathy, and the action of different cardioprotectant drugs thereon; and (4) hormonal effects. In humans, the use of FZ as an anti-ulcer drug and in controlling infectious diseases, especially opportunistic infections in AIDS patients, is described.

Original languageEnglish
Pages (from-to)343-360
Number of pages18
JournalVeterinary Research Communications
Volume23
Issue number6
DOIs
Publication statusPublished - 1999

Fingerprint

Furazolidone
furazolidone
Toxicology
Pharmacology
therapeutics
Research
Anti-Ulcer Agents
Drug Residues
drug residues
drugs
carcinogenicity
genotoxicity
cardiomyopathy
Opportunistic Infections
Therapeutics
Anti-Infective Agents
Cardiomyopathies
infectious diseases
Communicable Diseases
Acquired Immunodeficiency Syndrome

Keywords

  • Carcinogen
  • Cardiomyopathy
  • Furazolidone
  • Pharmacology
  • Therapeutics
  • Toxicity

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Pharmacological, therapeutic and toxicological properties of furazolidone : Some recent research. / Ali, B. H.

In: Veterinary Research Communications, Vol. 23, No. 6, 1999, p. 343-360.

Research output: Contribution to journalArticle

@article{d6bdd208b9dd45ca8c63d625bd546b23,
title = "Pharmacological, therapeutic and toxicological properties of furazolidone: Some recent research",
abstract = "Some of the recent publications on the pharmacological, therapeutic and toxicological properties of the antimicrobial agent furazolidone (FZ) are briefly reviewed. In animals, most of the recently published papers focus on (1) the methodology of measuring the residues of the drug and its metabolites in edible tissues: (2) the carcinogenicity and genotoxicity of FZ; (3) the cellular and molecular basis of FZ-induced cardiomyopathy, and the action of different cardioprotectant drugs thereon; and (4) hormonal effects. In humans, the use of FZ as an anti-ulcer drug and in controlling infectious diseases, especially opportunistic infections in AIDS patients, is described.",
keywords = "Carcinogen, Cardiomyopathy, Furazolidone, Pharmacology, Therapeutics, Toxicity",
author = "Ali, {B. H.}",
year = "1999",
doi = "10.1023/A:1006333608012",
language = "English",
volume = "23",
pages = "343--360",
journal = "Veterinary Research Communications",
issn = "0165-7380",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Pharmacological, therapeutic and toxicological properties of furazolidone

T2 - Some recent research

AU - Ali, B. H.

PY - 1999

Y1 - 1999

N2 - Some of the recent publications on the pharmacological, therapeutic and toxicological properties of the antimicrobial agent furazolidone (FZ) are briefly reviewed. In animals, most of the recently published papers focus on (1) the methodology of measuring the residues of the drug and its metabolites in edible tissues: (2) the carcinogenicity and genotoxicity of FZ; (3) the cellular and molecular basis of FZ-induced cardiomyopathy, and the action of different cardioprotectant drugs thereon; and (4) hormonal effects. In humans, the use of FZ as an anti-ulcer drug and in controlling infectious diseases, especially opportunistic infections in AIDS patients, is described.

AB - Some of the recent publications on the pharmacological, therapeutic and toxicological properties of the antimicrobial agent furazolidone (FZ) are briefly reviewed. In animals, most of the recently published papers focus on (1) the methodology of measuring the residues of the drug and its metabolites in edible tissues: (2) the carcinogenicity and genotoxicity of FZ; (3) the cellular and molecular basis of FZ-induced cardiomyopathy, and the action of different cardioprotectant drugs thereon; and (4) hormonal effects. In humans, the use of FZ as an anti-ulcer drug and in controlling infectious diseases, especially opportunistic infections in AIDS patients, is described.

KW - Carcinogen

KW - Cardiomyopathy

KW - Furazolidone

KW - Pharmacology

KW - Therapeutics

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=0032886658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032886658&partnerID=8YFLogxK

U2 - 10.1023/A:1006333608012

DO - 10.1023/A:1006333608012

M3 - Article

C2 - 10543364

AN - SCOPUS:0032886658

VL - 23

SP - 343

EP - 360

JO - Veterinary Research Communications

JF - Veterinary Research Communications

SN - 0165-7380

IS - 6

ER -